• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肺运动试验变量作为胸型结节病长期预后的预测因子。

Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

机构信息

Setor de Provas de Função Respiratória, Universidade do Estado do Rio de Janeiro, Rua Araguaia 1266, Rio de Janeiro, RJ, Brazil.

出版信息

Braz J Med Biol Res. 2012 Mar;45(3):256-63. doi: 10.1590/s0100-879x2012007500018. Epub 2012 Feb 16.

DOI:10.1590/s0100-879x2012007500018
PMID:22331135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3854197/
Abstract

Cardiopulmonary exercise testing (CPET) plays an important role in the assessment of functional capacity in patients with interstitial lung disease. The aim of this study was to identify CPET measures that might be helpful in predicting the vital capacity and diffusion capacity outcomes of patients with thoracic sarcoidosis. A longitudinal study was conducted on 42 nonsmoking patients with thoracic sarcoidosis (median age = 46.5 years, 22 females). At the first evaluation, spirometry, the measurement of single-breath carbon monoxide diffusing capacity (D LCOsb) and CPET were performed. Five years later, the patients underwent a second evaluation consisting of spirometry and D LCOsb measurement. After 5 years, forced vital capacity (FVC)% and D LCOsb% had decreased significantly [95.5 (82-105) vs 87.5 (58-103) and 93.5 (79-103) vs 84.5 (44-102), respectively; P < 0.0001 for both]. In CPET, the peak oxygen uptake, maximum respiratory rate, breathing reserve, alveolar-arterial oxygen pressure gradient at peak exercise (P(A-a)O2), and Δ SpO2 values showed a strong correlation with the relative differences for FVC% and D LCOsb% (P < 0.0001 for all). P(A-a)O2 ≥22 mmHg and breathing reserve ≤40% were identified as significant independent variables for the decline in pulmonary function. Patients with thoracic sarcoidosis showed a significant reduction in FVC% and D LCOsb% after 5 years of follow-up. These data show that the outcome measures of CPET are predictors of the decline of pulmonary function.

摘要

心肺运动测试(CPET)在评估间质性肺疾病患者的功能能力方面发挥着重要作用。本研究旨在确定 CPET 指标,这些指标可能有助于预测胸型结节病患者的肺活量和弥散能力的结果。对 42 名非吸烟的胸型结节病患者进行了一项纵向研究(中位年龄=46.5 岁,22 名女性)。在第一次评估时,进行了肺量测定、单口气一氧化碳弥散量(D LCOsb)测量和 CPET。5 年后,患者接受了第二次评估,包括肺量测定和 D LCOsb 测量。5 年后,用力肺活量(FVC)%和 D LCOsb%显著下降[95.5(82-105)与 87.5(58-103)和 93.5(79-103)与 84.5(44-102);均 P<0.0001]。在 CPET 中,峰值摄氧量、最大呼吸频率、呼吸储备、峰值运动时肺泡-动脉氧分压差(P(A-a)O2)和 ΔSpO2 值与 FVC%和 D LCOsb%的相对差异具有很强的相关性(均 P<0.0001)。P(A-a)O2≥22mmHg 和呼吸储备≤40%被确定为肺功能下降的显著独立变量。在 5 年的随访后,胸型结节病患者的 FVC%和 D LCOsb%显著下降。这些数据表明 CPET 的结果测量是预测肺功能下降的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c4/3854197/02db029dc4b3/0100-879X-bjmbr-45-03-256-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c4/3854197/02db029dc4b3/0100-879X-bjmbr-45-03-256-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c4/3854197/02db029dc4b3/0100-879X-bjmbr-45-03-256-gf01.jpg

相似文献

1
Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.心肺运动试验变量作为胸型结节病长期预后的预测因子。
Braz J Med Biol Res. 2012 Mar;45(3):256-63. doi: 10.1590/s0100-879x2012007500018. Epub 2012 Feb 16.
2
Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.结节病患者的肺活量测定、心肺运动试验及六分钟步行试验结果
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(3):185-194. doi: 10.36141/svdld.v36i3.7663. Epub 2019 May 1.
3
Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.比较结节病患者改良的穿梭步行试验和心肺运动试验。
Respirology. 2014 May;19(4):604-7. doi: 10.1111/resp.12276. Epub 2014 Mar 25.
4
Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis.胸型结节病患者心肺运动试验参数与计算机断层扫描结果的比较。
Lung. 2011 Oct;189(5):425-31. doi: 10.1007/s00408-011-9316-1. Epub 2011 Aug 20.
5
Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.血浆表面活性蛋白 B 和晚期糖基化终产物受体在肺结节病中的相反表现。
Respir Med. 2013 Oct;107(10):1617-24. doi: 10.1016/j.rmed.2013.07.019. Epub 2013 Aug 13.
6
Cardiopulmonary Function in Patients with Congenital Scoliosis: An Observational Study.先天性脊柱侧凸患者的心肺功能:一项观察性研究。
J Bone Joint Surg Am. 2019 Jun 19;101(12):1109-1118. doi: 10.2106/JBJS.18.00935.
7
Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease.先天性心脏病患儿肺功能受损及其与临床结局、运动能力和生活质量的关系。
Int J Cardiol. 2019 Jun 15;285:86-92. doi: 10.1016/j.ijcard.2019.02.069. Epub 2019 Mar 1.
8
Physical Functioning and Symptoms of Chronic Fatigue in Sarcoidosis Patients.结节病患者的身体机能和慢性疲劳症状。
Adv Exp Med Biol. 2018;1040:13-21. doi: 10.1007/5584_2017_85.
9
Pulmonary sarcoidosis: differences in lung function change over time.肺结节病:肺功能随时间变化的差异。
Thorax. 2024 Oct 16;79(11):1033-1039. doi: 10.1136/thorax-2023-221309.
10
Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation.心肺运动因素可预测接受肺移植评估的晚期间质性肺疾病患者的生存率。
Respir Med. 2017 May;126:59-67. doi: 10.1016/j.rmed.2017.03.022. Epub 2017 Mar 27.

引用本文的文献

1
Body composition, maximal fitness, and submaximal exercise function in people with interstitial lung disease.间质性肺疾病患者的身体成分、最大运动能力和亚极量运动功能
Respir Res. 2025 Apr 2;26(1):123. doi: 10.1186/s12931-025-03195-9.
2
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity.心肺运动试验在评估结节病分期和监测疾病活动方面,对肺量计检查和核成像检查都起到补充作用。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024017. doi: 10.36141/svdld.v41i1.15125.
3
Value of Cardiopulmonary Exercise Testing in Prognostic Assessment of Patients with Interstitial Lung Diseases.

本文引用的文献

1
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.结节病临床结局状态(COS)的定义:WASOG 工作组的结果
Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):56-64.
2
Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease.心肺运动试验在心肺疾病患者的临床评估中的应用
Circulation. 2011 Feb 15;123(6):668-80. doi: 10.1161/CIRCULATIONAHA.109.914788.
3
The impact of gas exchange measurement during exercise in pulmonary sarcoidosis.运动中气体交换测量对肺结节病的影响。
心肺运动试验在间质性肺疾病患者预后评估中的价值
J Clin Med. 2022 Mar 14;11(6):1609. doi: 10.3390/jcm11061609.
4
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.结节病:从症状到诊断的临床概述。
Cells. 2021 Mar 31;10(4):766. doi: 10.3390/cells10040766.
5
Long-Term Benefits of Tailored Exercise in Severe Sarcoidosis: A Case Report.特发性肺纤维化患者长期接受量身定制的运动干预:1 例报告。
Int J Environ Res Public Health. 2020 Dec 18;17(24):9512. doi: 10.3390/ijerph17249512.
6
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review.心肺运动试验在间质性肺疾病中的预后价值:一项系统评价。
ERJ Open Res. 2020 Aug 17;6(3). doi: 10.1183/23120541.00027-2020. eCollection 2020 Jul.
7
Long-Term Combined Training in Idiopathic Pulmonary Fibrosis: A Case Study.特发性肺纤维化的长期联合训练:案例研究。
Int J Environ Res Public Health. 2020 Jul 15;17(14):5091. doi: 10.3390/ijerph17145091.
8
Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.结节病患者的肺活量测定、心肺运动试验及六分钟步行试验结果
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(3):185-194. doi: 10.36141/svdld.v36i3.7663. Epub 2019 May 1.
9
Patient reported outcome measures (PROMs) in sarcoidosis.结节病患者报告结局量表(PROMs)
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):2-17. doi: 10.36141/svdld.v34i1.5760. Epub 2017 Apr 28.
10
Reduction of exercise capacity in sarcoidosis in relation to disease severity.结节病患者运动能力下降与疾病严重程度的关系。
Patient Prefer Adherence. 2015 Aug 18;9:1179-88. doi: 10.2147/PPA.S86465. eCollection 2015.
Respir Med. 2011 Jan;105(1):122-9. doi: 10.1016/j.rmed.2010.09.007. Epub 2010 Oct 6.
4
New reference values for forced spirometry in white adults in Brazil.巴西白人成年人用力肺活量的新参考值。
J Bras Pneumol. 2007 Jul-Aug;33(4):397-406. doi: 10.1590/s1806-37132007000400008.
5
Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis.结节病患者中度运动时肺气体交换受损的临床、影像学和功能预测因素。
Respiration. 2004 Jul-Aug;71(4):367-73. doi: 10.1159/000079641.
6
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.肺结节病中肺一氧化碳弥散能力的膜性和毛细血管血液成分:与运动气体交换的关系
Chest. 2004 Jun;125(6):2061-8. doi: 10.1378/chest.125.6.2061.
7
Two year prognosis of sarcoidosis: the ACCESS experience.结节病的两年预后:ACCESS研究经验
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Oct;20(3):204-11.
8
Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation.英格兰胸内结节病的预后。对136例患者进行五年观察后的回顾。
Br Med J. 1961 Nov 4;2(5261):1165-72. doi: 10.1136/bmj.2.5261.1165.
9
Clinical exercise testing.临床运动试验
Clin Chest Med. 2001 Dec;22(4):679-701, viii. doi: 10.1016/s0272-5231(05)70060-5.
10
Clinical characteristics of patients in a case control study of sarcoidosis.结节病病例对照研究中患者的临床特征
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885-9. doi: 10.1164/ajrccm.164.10.2104046.